Alliance Pharma Share Price | |
---|---|
Price | 34.55 |
Bid | 34.55 |
Ask | 34.70 |
Change | -0.40 (-1.14%) |
Volume | 662,526 |
Open | 35.00 |
High | 35.00 |
Low | 34.00 |
Prev. Close | 34.95 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £186.71m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 112 |
---|---|
Vol. Sold | 81,546 |
Sold Value | £28.18k |
Vol. Bought | 735,980 |
Bought Value | £255.79k |
PE Ratio | 203.23529 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.894% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
29-Apr-24 | 14:38:39 | 34.55 | 52 | Sell* | 34.55 | 34.70 | 17.97 | O Ordinary Trade was executed as an SI |
29-Apr-24 | 14:34:21 | 34.605 | 350 | Sell* | 34.55 | 34.70 | 121.12 | O Ordinary |
29-Apr-24 | 14:18:40 | 34.592 | 35 | Sell* | 34.55 | 34.70 | 12.11 | O Ordinary |
29-Apr-24 | 14:17:47 | 34.592 | 31 | Sell* | 34.55 | 34.70 | 10.72 | O Ordinary |
29-Apr-24 | 14:13:54 | 34.667 | 1,864 | Buy* | 34.55 | 34.70 | 646.19 | O Ordinary |
29-Apr-24 | 14:12:50 | 34.592 | 47 | Sell* | 34.55 | 34.70 | 16.26 | O Ordinary |
29-Apr-24 | 14:12:04 | 34.667 | 5,743 | Buy* | 34.55 | 34.70 | 1,991 | O Ordinary |
29-Apr-24 | 14:10:08 | 34.682 | 10 | Buy* | 34.55 | 34.70 | 3.47 | O Ordinary |
29-Apr-24 | 13:56:29 | 34.682 | 28 | Buy* | 34.55 | 34.70 | 9.71 | O Ordinary |
29-Apr-24 | 13:47:29 | 34.667 | 5,780 | Buy* | 34.55 | 34.70 | 2,004 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions